sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> drug and gene delivery devices market

report

Drug and Gene Delivery Devices Market, by Route of Administration (Oral, Injectables, Transdermal, Topical, Nasal, Inhalation, Ocular), Vector (Virus, Non Virus), Method (In-Situ, Ex-Vivo) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC261 February 2017 100+ FREE 10% CUSTOMIZATION

Drug delivery systems are in constant development owing to the changing treatment procedures and patient preference. For example, over the past, hormone replacement therapy was prescribed in the form of pills, but, now it is prescribed in the form of prefilled syringes, vaginal rings, patches, spray, and gel. The primary purpose of advancement of different forms of delivery systems is to enhance the ease of usage. The global drug and gene delivery devices market is expected to witness healthy growth during the forecast period. The rising demand and growth in the healthcare expenditure are expected to be some of the vital factors driving the growth of this market during the near future.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Meticulous understanding of the key new market opportunities in individual geographic regions/countries
  • Detailed analysis of the significant sustainability strategies adopted by the major players in this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The drug and gene delivery devices market growth is majorly driven by increasing investment by the key players to develop innovative drug delivery system.
  • Furthermore, rising focus on research and development of gene delivery systems due to the growth potential of gene therapy for the treatment of broad range of diseases is predicted to boost the market growth during the forecast period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s drug and gene delivery devices market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the drug and gene delivery devices market by the following segments:

  • Drug and Gene Delivery Devices Market, by Route of Administration
    • Oral
    • Injectables
    • Transdermal
    • Topical
    • Nasal
    • Inhalation
    • Ocular
  • Drug and Gene Delivery Devices Market, by Vector
    • Virus
    • Non Virus
  • Drug and Gene Delivery Devices Market, by Method
    • In-situ
    • Ex-vivo

KEY MARKET PLAYERS

Key players in the drug and gene delivery devices market include:

  • SIBIONO
  • F. Hoffmann-La Roche Ltd
  • Epeius Biotechnologies Corporation
  • Pfizer, Inc.
  • Unique N.V.
  • Johnson and Johnson
  • Human Stem Cells Institute 
  • Novartis AG
  • Shanghai Sunway Biotech Co., Ltd.
  • Becton, Dickinson and Company 

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. DRUG AND GENE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION
    1. Segment Share
    2. Route of Administration
      1. Oral
      2. Injectables
      3. Transdermal
      4. Topical
      5. Nasal
      6. Inhalation
      7. Ocular
  6. DRUG AND GENE DELIVERY DEVICES MARKET, BY VECTOR
    1. Segment Share
    2. Vector
      1. Virus
      2. Non Virus
  7. DRUG AND GENE DELIVERY DEVICES MARKET, BY METHOD
    1. Segment Share
    2. Method
      1. In-situ
      2. Ex-vivo
  8. DRUG AND GENE DELIVERY DEVICES MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Route of Administration
      3. By Vector
      4. By Method
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Route of Administration
      3. By Vector
      4. By Method
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Route of Administration
      3. By Vector
      4. By Method
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Route of Administration
      3. By Vector
      4. By Method
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. SIBIONO
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Epeius Biotechnologies Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Unique N.V.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Johnson and Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Human Stem Cells Institute 
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Shanghai Sunway Biotech Co., Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Becton, Dickinson and Company 
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX 
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us